bf/NASDAQ:AGIO_icon.jpeg

COM:AGIOS

Agios Pharmaceuticals, Inc.

  • Stock

Last Close

54.62

21/11 21:00

Market Cap

2.47B

Beta: -

Volume Today

360.45K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-29.45M
-
-45.58M
54.75%
-88.03M
93.15%
-71.47M
18.81%
4.10M
105.74%
11.01M
168.65%
15.44M
40.22%
12.34M
20.09%
13.78M
11.69%
average payables
3.49M
-
7.37M
111.06%
12.91M
75.08%
15.93M
23.39%
19.94M
25.17%
20.32M
1.94%
19.89M
2.14%
24.37M
22.54%
21.77M
10.66%
17.66M
18.90%
14.20M
19.59%
average receivables
238K
-
6.57M
2,661.13%
12.13M
84.63%
9.96M
17.94%
6.08M
38.97%
7.14M
17.51%
12.88M
80.39%
20.36M
58.06%
14.89M
26.87%
3.29M
77.89%
2.51M
23.82%
book value per share
8.53
-
12.60
47.78%
9.22
26.85%
9.16
0.60%
8.06
12.05%
11.97
48.56%
10.68
10.84%
5.79
45.77%
21.37
269.14%
20.09
6.00%
14.57
27.47%
capex per share
-0.08
-
-0.07
21.59%
-0.54
718.47%
-0.25
52.96%
-0.10
60.81%
-0.12
22.50%
-0.20
66.74%
-0.22
6.51%
-0.09
56.05%
-0.09
6.20%
-0.02
79.85%
capex to depreciation
-0.90
-
-1.62
80.40%
-6.03
272.19%
-1.74
71.21%
-0.72
58.59%
-0.97
35.41%
-1.51
54.51%
-1.49
0.78%
-0.62
58.39%
-0.57
8.27%
-0.15
73.53%
capex to operating cash flow
0.02
-
0.04
62.73%
0.26
601.85%
-0.26
198.12%
0.02
106.31%
0.02
41.47%
0.03
43.10%
0.05
56.14%
0.01
72.51%
0.02
11.90%
0.00
78.61%
capex to revenue
-0.05
-
-0.03
33.06%
-0.34
905.96%
-0.14
58.41%
-0.11
24.17%
-0.07
31.20%
-0.10
39.46%
-0.07
28.92%
-0.34
-
-0.04
89.13%
cash per share
10.82
-
10.16
6.09%
16.60
63.33%
24.39
46.94%
19.08
21.75%
22.99
20.50%
9.42
59.05%
8.30
11.81%
16.87
103.22%
14.29
15.30%
13.96
2.33%
days of inventory on hand
227.05
-
2.03K
794.86%
1.91K
5.87%
1.82K
-
732.61
59.72%
days payables outstanding
4.67K
-
6.07K
29.90%
3.49K
42.44%
3.99K
-
375.60
90.58%
days sales outstanding
6.80
-
70.74
940.22%
71.61
1.23%
43.42
39.37%
32.58
24.97%
40.38
23.95%
47.42
17.44%
45.62
3.79%
56.54
-
38.24
32.38%
debt to assets
0.04
-
0.03
28.27%
-0.01
138.40%
-0.25
2,127.98%
-0.20
17.85%
-0.07
65.97%
0.13
283.15%
0.12
3.35%
0.07
45.24%
0.07
2.40%
0.08
11.10%
debt to equity
0.06
-
0.03
45.66%
-0.01
140.32%
-0.43
3,060.24%
-0.34
22.14%
-0.09
74.03%
0.18
303.99%
0.26
48.39%
0.08
71.46%
0.08
3.54%
0.09
14.08%
dividend yield
earnings yield
-0.11
-
-0.01
86.71%
-0.05
241.58%
-0.12
150.88%
-0.12
2.81%
-0.13
10.62%
-0.14
5.93%
-0.11
19.01%
0.81
820.31%
-0.05
106.00%
-0.28
486.23%
enterprise value
297.63M
-
3.76B
1,162.65%
2.05B
45.34%
1.06B
48.43%
2.10B
97.86%
1.84B
12.10%
2.90B
57.29%
2.97B
2.41%
1.88B
36.62%
1.48B
21.05%
1.22B
17.63%
enterprise value over ebitda
-7.65
-
-69.42
806.95%
-17.30
75.07%
-5.27
69.55%
-6.53
23.96%
-5.08
22.21%
-6.93
36.32%
-9.59
38.38%
-4.88
49.05%
-2.82
42.29%
-3.18
12.74%
ev to operating cash flow
-5.28
-
-63.32
1,099.83%
-26.69
57.84%
27.47
202.90%
-7.35
126.75%
-6.05
17.64%
-7.82
29.19%
-10.21
30.55%
-4.62
54.75%
-4.80
3.91%
-4.13
13.89%
ev to sales
11.65
-
57.50
393.56%
34.74
39.58%
15.15
56.38%
48.72
221.51%
19.52
59.94%
24.57
25.91%
14.60
40.57%
104.28
-
45.60
56.27%
free cash flow per share
-3.74
-
-1.83
51.14%
-2.59
41.88%
0.73
128.22%
-6.22
949.78%
-5.42
12.83%
-6.38
17.65%
-4.43
30.57%
-6.83
54.25%
-5.74
16.04%
-5.34
6.97%
free cash flow yield
-0.16
-
-0.02
89.56%
-0.04
144.85%
0.02
143.90%
-0.11
720.28%
-0.12
8.08%
-0.13
13.60%
-0.10
23.48%
-0.21
103.33%
-0.20
1.71%
-0.24
17.31%
graham net net
6.32
-
8.44
33.51%
14.04
66.40%
17.47
24.48%
12.47
28.63%
20.16
61.64%
5.50
72.73%
2.11
61.54%
14.65
593.00%
11.88
18.89%
11.90
0.17%
graham number
22.15
-
21.23
4.15%
25.55
20.33%
32.34
26.61%
35.00
8.21%
40.29
15.13%
39.85
1.10%
25.16
36.87%
112.99
349.12%
24.80
78.05%
45.55
83.64%
income quality
1.43
-
1.11
22.49%
0.65
41.08%
-0.19
129.73%
0.91
566.53%
0.88
2.94%
0.90
2.38%
0.89
1.39%
1.14
28.64%
1.34
16.86%
0.84
37.02%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-706.96
-
-266.67
62.28%
-122.62
54.02%
-79.95
34.80%
-52.38
34.48%
-22.03
57.94%
-17.73
-
-30.41
-
interest debt per share
0.53
-
0.43
19.11%
-0.10
123.09%
-3.88
3,791.70%
-2.57
33.78%
-0.76
70.60%
1.89
350.89%
1.78
5.88%
1.61
9.92%
1.80
11.87%
1.29
28.00%
inventory turnover
1.61
-
0.18
88.83%
0.19
6.23%
0.20
-
0.50
148.29%
invested capital
0.06
-
0.03
45.66%
-0.01
140.32%
-0.43
3,060.24%
-0.34
22.14%
-0.09
74.03%
0.18
303.99%
0.26
48.39%
0.08
71.46%
0.08
3.54%
0.09
14.08%
market cap
369.19M
-
3.77B
921.71%
2.43B
35.58%
1.63B
32.81%
2.66B
63.13%
2.65B
0.60%
2.86B
8.20%
2.99B
4.36%
1.99B
33.54%
1.54B
22.57%
1.24B
19.44%
net current asset value
100.02M
-
292.01M
191.94%
262.38M
10.15%
299.39M
14.10%
206.37M
31.07%
442.86M
114.60%
361.49M
18.37%
183.22M
49.31%
918.47M
401.28%
694.87M
24.35%
707.74M
1.85%
net debt to ebitda
1.84
-
0.26
85.92%
3.17
1,121.81%
2.85
9.89%
1.77
37.98%
2.22
25.55%
-0.08
103.52%
0.07
191.80%
0.28
283.31%
0.10
63.05%
0.04
58.61%
net income per share
-2.56
-
-1.59
37.83%
-3.15
97.93%
-5.07
61.27%
-6.75
33.16%
-6.03
10.78%
-6.61
9.70%
-4.86
26.51%
26.55
646.42%
-1.36
105.13%
-6.33
364.94%
operating cash flow per share
-3.66
-
-1.76
51.82%
-2.06
16.61%
0.99
147.94%
-6.12
721.21%
-5.30
13.40%
-6.18
16.52%
-4.21
31.79%
-6.74
59.90%
-5.65
16.17%
-5.32
5.82%
payables turnover
0.08
-
0.06
23.02%
0.10
73.73%
0.09
-
0.97
961.66%
receivables turnover
53.67
-
5.16
90.39%
5.10
1.22%
8.41
64.93%
11.20
33.27%
9.04
19.32%
7.70
14.85%
8.00
3.94%
6.46
-
9.55
47.88%
research and ddevelopement to revenue
2.13
-
1.54
28.01%
2.40
56.21%
3.15
31.31%
6.80
116.02%
3.62
46.86%
3.48
3.64%
1.81
48.10%
19.66
-
10.77
45.21%
return on tangible assets
-0.20
-
-0.11
44.46%
-0.28
157.67%
-0.32
14.38%
-0.51
59.76%
-0.40
21.30%
-0.45
10.46%
-0.39
11.73%
1.12
384.00%
-0.06
105.39%
-0.38
524.24%
revenue per share
1.66
-
1.94
17.13%
1.58
18.64%
1.79
13.09%
0.92
48.32%
1.64
78.05%
1.97
19.56%
2.94
49.84%
0.26
-
0.48
85.45%
roe
-0.30
-
-0.13
57.93%
-0.34
170.57%
-0.55
62.24%
-0.84
51.41%
-0.50
39.94%
-0.62
23.03%
-0.84
35.51%
1.24
248.02%
-0.07
105.45%
-0.43
541.00%
roic
-0.28
-
-0.12
56.68%
-0.35
183.80%
-0.96
175.02%
-1.26
31.70%
-0.63
49.75%
-0.47
25.12%
-0.53
12.10%
1.16
318.18%
-0.10
108.49%
-0.42
323.41%
sales general and administrative to revenue
0.39
-
0.29
24.73%
0.61
108.11%
0.73
19.18%
1.65
127.90%
shareholders equity per share
8.53
-
12.60
47.78%
9.22
26.85%
9.16
0.60%
8.06
12.05%
11.97
48.56%
10.68
10.84%
5.79
45.77%
21.37
269.14%
20.09
6.00%
14.57
27.47%
stock based compensation to revenue
0.12
-
0.18
48.44%
0.54
207.11%
0.60
11.38%
1.11
84.60%
0.78
30.08%
0.61
21.03%
0.37
39.77%
3.46
-
1.67
51.79%
tangible asset value
131.48M
-
424.37M
222.76%
345.12M
18.67%
358.59M
3.90%
375.50M
4.72%
687.54M
83.10%
640.53M
6.84%
399.50M
37.63%
1.29B
223.40%
1.10B
14.80%
811.02M
26.33%
tangible book value per share
8.53
-
12.60
47.78%
9.22
26.85%
9.16
0.60%
8.06
12.05%
11.97
48.56%
10.68
10.84%
5.79
45.77%
21.37
269.14%
20.09
6.00%
14.57
27.47%
working capital
132.82M
-
298.46M
124.71%
284.44M
4.70%
471.46M
65.75%
350.32M
25.69%
520.28M
48.51%
518.82M
0.28%
542.28M
4.52%
1.00B
85.22%
770.14M
23.32%
765.88M
0.55%

All numbers in (except ratios and percentages)